Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.620 EUR
−32.53 M EUR
13.31 M EUR
70.48 M
About NOVACYT
Sector
Industry
CEO
Lyn Dafydd Rees
Website
Headquarters
Vélizy-Villacoublay
Founded
2016
ISIN
FR0010397232
FIGI
BBG003CDTG68
Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. It operates through the following segments: Primer Design, IT-IS International, and Corporate. The Primer Design segment focuses on the activities of Primer Design Ltd, which is a designer, manufacturer, and marketer of molecular real-time qPCR testing devices and reagents. The IT-IS International segment is involved in IT-IS International Ltd, a diagnostic instrument development and manufacturing company specializing in the development of PCR devices for the life sciences and food testing industry. The Corporate segment includes group central and corporate costs. The company was founded by Eric Peltier, Gerald Ulrich, and Jean-Pierre Crinelli on July 3, 2006 and is headquartered in Velizy-Villacoublay, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALNOV is 0.576 EUR — it has decreased by −0.52% in the past 24 hours. Watch NOVACYT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange NOVACYT stocks are traded under the ticker ALNOV.
ALNOV stock has fallen by −7.25% compared to the previous week, the month change is a −17.71% fall, over the last year NOVACYT has showed a −8.28% decrease.
ALNOV reached its all-time high on Oct 26, 2020 with the price of 13.960 EUR, and its all-time low was 0.061 EUR and was reached on Oct 23, 2019. View more price dynamics on ALNOV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALNOV stock is 2.99% volatile and has beta coefficient of 3.08. Track NOVACYT stock price on the chart and check out the list of the most volatile stocks — is NOVACYT there?
Today NOVACYT has the market capitalization of 40.68 M, it has decreased by −3.82% over the last week.
Yes, you can track NOVACYT financials in yearly and quarterly reports right on TradingView.
NOVACYT is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
ALNOV net income for the last half-year is −20.71 M EUR, while the previous report showed −23.10 M EUR of net income which accounts for 10.36% change. Track more NOVACYT financial stats to get the full picture.
No, ALNOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVACYT EBITDA is −16.22 M EUR, and current EBITDA margin is −118.90%. See more stats in NOVACYT financial statements.
Like other stocks, ALNOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVACYT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVACYT technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVACYT stock shows the sell signal. See more of NOVACYT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.